Effect of Endorphin Massage on Surgical Fear, Anxiety and Pain Before Mastectomy
Mastectomy
The Effect of Endorphin Massage Applied Before Mastectomy Surgery on Surgical Fear, Anxiety and Pain Levels
1 other identifier
interventional
82
0 countries
N/A
Brief Summary
This research is planned to investigate the effect of endorphin massage applied before mastectomy surgery on surgical anxiety and fear and pain. This was a randomized, controlled experimental study. The sample comprised 82 patients who underwent mastectomy surgery. This research will be conducted between January 2024 and November 2025 at the Atatürk University Health Practice and Research Hospital, Breast-Endocrine Clinic.The data will be collected using the Introductory Information Form, Surgical Anxiety Scale, Surgical Fear Scale, and Visual Analog Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Mar 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2024
CompletedFirst Posted
Study publicly available on registry
January 1, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFebruary 14, 2025
December 1, 2024
6 months
December 18, 2024
February 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Visual Analog Scale (VAS)
For pain assessment, the patient is asked to indicate the perceived intensity of pain along a 100 mm horizontal line, and this rating is measured starting from the left side. Patients are asked to score their pain level on a scale from 0 to 10 on the horizontal line. 0 represents no pain, and 10 represents unbearable pain. Due to its simplicity, validity, and reliability, this scale is considered the most appropriate tool for describing pain intensity.
0th hour
Visual Analog Scale (VAS)
For pain assessment, the patient is asked to indicate the perceived intensity of pain along a 100 mm horizontal line, and this rating is measured starting from the left side. Patients are asked to score their pain level on a scale from 0 to 10 on the horizontal line. 0 represents no pain, and 10 represents unbearable pain. Due to its simplicity, validity, and reliability, this scale is considered the most appropriate tool for describing pain intensity.
4th hour
Visual Analog Scale (VAS)
For pain assessment, the patient is asked to indicate the perceived intensity of pain along a 100 mm horizontal line, and this rating is measured starting from the left side. Patients are asked to score their pain level on a scale from 0 to 10 on the horizontal line. 0 represents no pain, and 10 represents unbearable pain. Due to its simplicity, validity, and reliability, this scale is considered the most appropriate tool for describing pain intensity.
8th hour
Visual Analog Scale (VAS)
For pain assessment, the patient is asked to indicate the perceived intensity of pain along a 100 mm horizontal line, and this rating is measured starting from the left side. Patients are asked to score their pain level on a scale from 0 to 10 on the horizontal line. 0 represents no pain, and 10 represents unbearable pain. Due to its simplicity, validity, and reliability, this scale is considered the most appropriate tool for describing pain intensity.
16th hour
Visual Analog Scale (VAS)
For pain assessment, the patient is asked to indicate the perceived intensity of pain along a 100 mm horizontal line, and this rating is measured starting from the left side. Patients are asked to score their pain level on a scale from 0 to 10 on the horizontal line. 0 represents no pain, and 10 represents unbearable pain. Due to its simplicity, validity, and reliability, this scale is considered the most appropriate tool for describing pain intensity.
24th hour
Surgical Fear Scale
The scale consists of 8 items on a 0-10 numerical scale. This scale, which has two subdimensions, measures the fear related to the short-term and long-term outcomes of the surgical intervention. Items 1-4 assess the fear of the short-term outcomes of the surgery, while items 5-8 measure the fear of the long-term outcomes of the surgery. An increase in the scale score indicates that the fear of surgery is high.
1 day before surgery]
Surgical Fear Scale
: 1 day before surgery\]
On the day of surgery
Surgical Anxiety Scale
The scale has three subdimensions: Health-Related Anxiety (items 7, 8, 9, 10, 12, and 13), Recovery-Related Anxiety (items 2, 14, 16, and 17), and Procedure-Related Anxiety (items 1, 3, 4, and 5). The total score of the Surgical Anxiety Scale (SAS) is obtained by summing the scores of the subdimension items and the three items not included in any subdimension. The lowest possible score on the scale is 0, and the highest score is 68. As the score increases, the level of surgical anxiety is considered higher.
1 day before surgery
Surgical Anxiety Scale
The scale has three subdimensions: Health-Related Anxiety (items 7, 8, 9, 10, 12, and 13), Recovery-Related Anxiety (items 2, 14, 16, and 17), and Procedure-Related Anxiety (items 1, 3, 4, and 5). The total score of the Surgical Anxiety Scale (SAS) is obtained by summing the scores of the subdimension items and the three items not included in any subdimension. The lowest possible score on the scale is 0, and the highest score is 68. As the score increases, the level of surgical anxiety is considered higher.
On the day of surgery]
Study Arms (2)
Endhorphin massage grup
EXPERIMENTALThe group that perform endorphin massage
No interventional Grup 2
NO INTERVENTIONThe group that does not perform endorphin massage
Interventions
For Group 1 (experimental group), patients admitted to the clinic one day before surgery will complete the first two sections of the Patient Diagnosis Form (I. Individual characteristics and II. Health and illness-related data), the Surgical Fear and Anxiety Scale, and the VAS scales after the endorphin massage. The patients will be informed that the endorphin massage will last approximately 20 minutes. According to evidence-based current guidelines, it is stated that the intensity of the patient's pain should be assessed during the preoperative period for pain management planning and goals in the postoperative period. Therefore, patients' pain scores will also be recorded preoperatively using the VAS scale. On the morning of the surgery, before going to the operating room, the endorphin massage will be repeated, and the scales will be applied again. After surgery, patients will have their pain levels measured using the VAS at hours 0, 4, 8, 16, and 24, and the amount of analgesics tak
Eligibility Criteria
You may qualify if:
- Aged 18 and above
- Those who are aware of their diagnosis
- Receiving 4-6 cycles of neoadjuvant treatment on a monthly basis
- Scheduled for their first mastectomy surgery
- Those whose cognitive level is suitable for applying the scales
You may not qualify if:
- Patients with metastasis
- Patients with a diagnosed severe mental disorder
- Patients enrolled in a different study conducted in the clinic
- Patients who cannot comply with the study process and conditions
- Patients who withdraw from the study at their own request
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MERVE KAYA
Ataturk University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Single (Participant)
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 18, 2024
First Posted
January 1, 2025
Study Start
March 1, 2025
Primary Completion
September 1, 2025
Study Completion
December 1, 2025
Last Updated
February 14, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share